Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Detemir vs Insulin Glargine in Type 2 Diabetes
NCT00656422Phase 3Terminated
- Sponsor
- University Hospital Tübingen
- Start
- Nov 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
Phase 3, randomised trial in type 2 diabetes mellitus (T2DM) comparing insulin Levemir with insulin Lantus (2 arms). Primary endpoint: Changes in hepatic fat content at 52 weeks. Started Nov 2007; status: terminated.
02
Drugs
insulin detemirinsulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00656422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00656422.